Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma
Jianhua Liu(First Hospital of Jilin University), Bai Ji(Jilin University)
Cited by 92
Related Papers
Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells
|International Journal of Medical Sciences|2019|38